Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer

<div>The Kaplan–Meier survival curve estimates the relationship between prognosis and mutation number in stage IIIA-N2 NSCLC patients: (a) disease-free survival (DFS); (b) local-regional recurrence-free survival (LRFS); (c) local-regional progression-free survival (LPFS).</div>

Disease Markers

fig2

Figure 2

Figure 2: Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer 